Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

8.090 -0.820 (-9.20%)

Delayed Quote Updated: 3:26 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

43 Stocks Moving In Friday's Mid-Day Session ↗

March 04, 2022

Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after...

Via Benzinga

24 Stocks Moving in Friday's Pre-Market Session ↗

March 04, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for...

Via Benzinga

Why Is Tonix Pharmaceuticals (TNXP) Stock Up Today? ↗

March 03, 2022

Here's the big news that's driving shares of Tonix Pharmaceuticals' TNXP stock more than 40% higher on a mixed day in the markets.

Via InvestorPlace

Could This Be A Potential New Weapon In The Fight Against COVID-19? ↗

February 01, 2022

Photo by Mufid Majnun on Unsplash

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

63 Biggest Movers From Yesterday ↗

March 04, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday. DBV Technologies S.A. (...

Via Benzinga

Tonix Pharmaceuticals Rockets Higher Thursday: Why Is The Penny Stock Flying? ↗

March 03, 2022

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are rallying higher Thursday after the company announced the FDA has granted Orphan-Drug Designation for TNX-2900 for the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 03, 2022

Gainers Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 49.1% to $0.28 during Thursday's regular session. As of 12:31 EST, Tonix Pharmaceuticals's stock is trading...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 03, 2022

Gainers Kiromic BioPharma (NASDAQ:KRBP) shares rose 32.5% to $1.04 during Thursday's pre-market session. The company's market cap stands at $16.0 million. DBV...

Via Benzinga

Tonix Pharma Inks Research Pact For Oxytocin In Eating Disorder ↗

February 28, 2022

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has entered into a sponsored research agreement with Inserm Transfert and Aix-Marseille Université to study...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 08, 2022

Good morning! We've got another busy day ahead of us so let's get right into it with the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

February 22, 2022

During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 20, 2022

During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive (NASDAQ:RIVN) was the largest...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 18, 2022

On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...

Via Benzinga

20 Stocks Moving in Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose...

Via Benzinga

Tonix Pharma, Kansas University Join Forces To Work On Next-Gen mRNA-Based COVID-19 Vaccine ↗

January 04, 2022

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced an exclusive option agreement and research collaboration with Kansas State University (K-State) to...

Via Benzinga

18 Stocks Moving in Monday's Pre-Market Session ↗

January 03, 2022

Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

December 30, 2021

Gainers BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) rose 33.6% to $3.10 in pre-market trading. BiondVax reported successful closing of $9.8 million follow-on underwritten...

Via Benzinga

The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO ↗

December 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

December 14, 2021

Gainers MIND Technology, Inc. (NASDAQ: MIND) rose 37.2% to $1.88 in pre-market trading after the company reported it entered into a Cooperative Research and Development Agreement...

Via Benzinga

20 Stocks Moving in Monday's Pre-Market Session ↗

November 29, 2021

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results...

Via Benzinga

56 Biggest Movers From Yesterday ↗

November 24, 2021

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating...

Via Benzinga

Why Tonix Pharmaceuticals Is Up by 6% Today ↗

November 23, 2021

The company's path to regulatory approval for a key pipeline drug just got a bit shorter.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA

Via Benzinga

36 Stocks Moving In Tuesday's Mid-Day Session ↗

November 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 216.6% to $7.00 after the company announced its subsidiary Pasithea Clinics has been approved to provide...

Via Benzinga

BBY Stock Alert: Why Best Buy Investors Are Getting Battered Today ↗

November 23, 2021

Best Buy (BBY) stock is taking a beating on Tuesday despite the company beating estimates in its most recent earnings report.

Via InvestorPlace

FDA Clears Tonix Pharma's Human Trial With Intranasal Oxytocin For Migraine ↗

November 23, 2021

The FDA has signed off Tonix Pharmaceuticals Holding Corp's (NASDAQ: TNXP) Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for...

Via Benzinga

TNXP Stock Alert: The Migraine News Sending Tonix Pharmaceuticals Soaring ↗

November 23, 2021

TNXP stock is soaring 20% on Tuesday after Tonix Pharmaceuticals' treatment for migraines received a key FDA clearance.

Via InvestorPlace

The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug ↗

November 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.